GlaxoSmithKline
GSK
#126
Rank
$113.46 B
Marketcap
$45.10
Share price
0.49%
Change (1 day)
17.57%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: $113.46 Billion

As of January 2022 GlaxoSmithKline has a market cap of $113.46 Billion. This makes GlaxoSmithKline the world's 126th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of GlaxoSmithKline from 2001 to 2022

Year Market cap Change
2022$113.46 B3.06%
2021$110.09 B19.98%
2020$91.76 B-21.15%
2019$116.38 B23.9%
2018$93.93 B6.6%
2017$88.11 B-6.48%
2016$94.22 B-4.88%
2015$99.05 B-4.91%
2014$104.16 B-19.26%
2013$129.00 B21.97%
2012$105.76 B-8.18%
2011$115.19 B13.05%
2010$101.89 B-7.08%
2009$109.65 B13.45%
2008$96.66 B-30.35%
2007$138.78 B-8.6%
2006$151.83 B3.03%
2005$147.36 B4.74%
2004$140.69 B6.84%
2003$131.68 B16.71%
2002$112.83 B-26.62%
2001$153.76 B

End of Day market cap according to different sources

On Jan 22nd, 2022 the market cap of GlaxoSmithKline was reported to be:

$113.46 Billion
by Yahoo Finance
$113.46 Billion
by CompaniesMarketCap
$113.46 Billion
by Nasdaq
$112.04 Billion
by Reuters
$113.45 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$196.20 B 72.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$296.30 B 161.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$129.86 B 14.45%๐Ÿ‡ซ๐Ÿ‡ท France
$202.02 B 78.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$183.13 B 61.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.65 B-91.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.54 B-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA